Celestica Inc (CLS) stock
CLSNYSEPrinted Circuit BoardsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 15/30
$240.34−13.69 (-5.39%)
Close on Nov 13, 2026Market cap $30.31BP/E 22.8Yield –
Celestica r&d expenses
Research and development expenses are spending on new products and technology.
Celestica's R&D Expenses for the twelve months ending Sep 30, 2026 was $168.90M, up 51.6% year over year. For fiscal 2025 it was $118.20M, up 51.5% from the year before. Over ten years it grew 17.7% a year on average. The highest annual figure on record is $118.20M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.20M | +51.5% |
| FY2024 | Dec 31, 2024 | $78.00M | +28.1% |
| FY2023 | Dec 31, 2023 | $60.90M | +31.5% |
| FY2022 | Dec 31, 2022 | $46.30M | +20.6% |
| FY2021 | Dec 31, 2021 | $38.40M | +28.4% |
| FY2020 | Dec 31, 2020 | $29.90M | +5.3% |
| FY2019 | Dec 31, 2019 | $28.40M | -1.4% |
| FY2018 | Dec 31, 2018 | $28.80M | +9.9% |
| FY2017 | Dec 31, 2017 | $26.20M | +5.2% |
| FY2016 | Dec 31, 2016 | $24.90M | +7.3% |
| FY2015 | Dec 31, 2015 | $23.20M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $51.20M | +40.7% |
| Q2 FY2026 | Jun 30, 2026 | $46.30M | +36.2% |
| Q1 FY2026 | Mar 31, 2026 | $41.20M | +134.1% |
| Q4 FY2025 | Dec 31, 2025 | $30.20M | +29.1% |
| Q3 FY2025 | Sep 30, 2025 | $36.40M | +94.7% |
| Q2 FY2025 | Jun 30, 2025 | $34.00M | +75.3% |
| Q1 FY2025 | Mar 31, 2025 | $17.60M | +6.7% |
| Q4 FY2024 | Dec 31, 2024 | $23.40M | – |
| Q3 FY2024 | Sep 30, 2024 | $18.70M | – |
| Q2 FY2024 | Jun 30, 2024 | $19.40M | – |
| Q1 FY2024 | Mar 31, 2024 | $16.50M | – |
See a number that looks wrong?